Streetbeat News

Stock Prices

CCCC

C4 Therapeutics (CCCC) will host a webcast to present new Phase 1 dose escalation data for relapsed refractory multiple myeloma from their ongoing Phase 1/2 clinical trial of CFT7455 on December 12, 2023.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 12:15 pm

RLYB

Rallybio has released preliminary data from the completed multiple dose cohort of their Phase 1 safety and pharmacokinetics study for RLY212. RLY212 is being developed for the prevention of fetal and neonatal alloimmune thrombocytopenia, a condition that can cause bleeding in the brain and other organs of fetuses and newborns.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 12:14 pm

FRLN

HC Wainwright & Co. analyst Patrick Trucchio has downgraded Freeline Therapeutics (NASDAQ:FRLN) from Buy to Neutral and reduced the price target from $15 to $6.5.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 12:10 pm

CRWD

HPE

INTU

NTAP

PDD

QQQ

SPLK

SPY

WDAY

Stock futures indicate a cautious sentiment as traders await consumer confidence and house price data, along with Fed speeches. The energy sector may benefit from oil's rebound ahead of the OPEC+ meeting. The S&P 500 is trading above analysts' 12-month consensus forecast, which is seen as a bullish signal. Retail stocks are in focus due to Cyber Monday sales, while several companies including Zscaler, PDD Holdings, CrowdStrike, Hewlett Packard Enterprise, Intuit, Splunk, NetApp, and Workday are set to report earnings. Crude oil futures are up, and Bitcoin has risen above $37,000.

Portfolio Pulse from Shanthi Rexaline

November 28, 2023 | 12:06 pm

DRCT

GSAT

MNY

ROKU

TRUE

Five tech and telecom stocks with high RSI values, indicating they may be overbought, are Direct Digital Holdings, Inc. (DRCT), MoneyHero Limited (MNY), Roku, Inc. (ROKU), TrueCar, Inc. (TRUE), and Globalstar, Inc. (GSAT). DRCT and TRUE reported better-than-expected financial results, while MNY and GSAT saw significant stock jumps. ROKU received an analyst upgrade with a new price target.

Portfolio Pulse from Lisa Levin

November 28, 2023 | 12:01 pm

DBI

Analysts have maintained an indifferent stance on Designer Brands (NYSE:DBI) with 5 neutral ratings in the last quarter. The average price target is $11.4, representing an upside from the current price of $10.76. This target has increased by 34.12% from the previous target of $8.50. Analysts determine ratings by forecasting a company's future earnings and stability.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 12:00 pm

BABA

Alibaba Group Holding Limited (NYSE:BABA) stock is trading lower after reports of a second outage in its cloud unit within a month. The disruption affected customers in China, Hong Kong, and the U.S., impacting various database management products. The company, which holds a significant market share in China's cloud market, also faced a similar issue in November. Concerns over the reliability of Alibaba Cloud's services have been raised. Additionally, Alibaba halted plans to spin off its cloud business and closed its quantum computing lab, signaling cost-cutting efforts. BABA shares are down 16.1% YTD and dropped 1.0% in premarket trading.

Portfolio Pulse from Anusuya Lahiri

November 28, 2023 | 12:00 pm

MRUS

Merus (NASDAQ:MRUS) has received 4 bullish analyst ratings in the last quarter with an average price target of $43.0, representing an upside from the current price of $24.21. This is a 4.44% decrease from the previous average price target of $45.00. Analysts typically review stocks quarterly or after major company updates, considering financial performance and market risks.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 12:00 pm

SHOP

Over the last quarter, Shopify (NYSE:SHOP) received 9 analyst ratings: 2 bullish, 2 somewhat bullish, 4 indifferent, 1 somewhat bearish, and 0 bearish. The average 12-month price target for Shopify is $62.56, with a high of $72.00 and a low of $55.00. This average has decreased by 1.01% from the previous target of $63.20. Analyst ratings are based on information from company calls, financial statements, and insider conversations.

Portfolio Pulse from Benzinga Insights

November 28, 2023 | 12:00 pm

LASR

Benchmark analyst Mark Miller has upgraded nLight (NASDAQ:LASR) from Hold to Speculative Buy and set a price target of $17.

Portfolio Pulse from Benzinga Newsdesk

November 28, 2023 | 11:52 am